Risk factor
Very poor trading liquidity
Profitability factor
Undervalued vs peers
About
KNC Laboratories Co., Ltd. engages in research, development, and production solutions for organic chemicals. Its operations are carried out through the following business divisions: Functional Materials Business, Pharmaceutical Business, and Bio Business. The Functional Materials Business division provides display materials, chemicals for semiconductor manufacturing, carbon nanotube dispersions, etc. The Pharmaceutical Business division provides compounds for pharmaceutical research and development. The Bio Business Division provides auxiliary agents for antibody drug manufacturing. The company was founded on January 22, 1985 and is headquartered in Kobe, Japan.
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD.